Chiome Bioscience Inc. [4583.T]
TOKYO, Apr 28 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the exercise of its 23rd series of warrant shares (with adjustment clause) during the period from April 1 to April 27, 2026.
A total of 1,456,200 warrants were exercised, representing 10.70% of the total issuance. As of April 1, there were 90,125 unexercised warrants remaining, equivalent to 9,012,500 shares. By the end of the reporting period, the number of unexercised warrants had decreased to 75,563. Exercise details showed significant activity on several days.
On April 1, 200,000 shares were transferred, followed by 100,000 shares on April 6, 238,800 shares on April 8, and 150,000 shares on April 9. Additional notable exercises occurred on April 14, April 16, April 17, April 20, and April 27, with respective share transfers of 1,500, 455, 1,000, 402, and 1,186. The exercise price remained consistent at ¥94.80 per share throughout much of the period, except for adjustments noted on certain days. As of the latest report, the outstanding ordinary shares stood at 72,651,300, including 22,729 treasury shares.
🟢 Confidence: High AI-translated content.